Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
915 questions in 93 reviews · Emergency and Critical Care
current versionsNo studies 141 · 15.4%Ungraded 22 · 2.4%Very low 216 · 23.6%Low 272 · 29.7%Moderate 188 · 20.5%High 76 · 8.3%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Polyclonal intravenous immunoglobulin (IVIG) vs placebo or no intervention Low risk of bias adult studies, mortality all‐cause ‐ IgM‐enriched IVIG · adult patients with sepsis, severe sepsis and septic shock Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock (2013) · Cochrane | RR 0.82 [0.56, 1.19] | 2 studies · 262 participants | Moderate |
Monoclonal antibodies vs placebo Anti‐endotoxins versus placebo, all‐cause mortality · patients with sepsis, severe sepsis, septic shock Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock (2013) · Cochrane | RR 0.92 [0.79, 1.06] | 8 studies · 4676 participants | Low |
Intervention NR ICU length of stay (general intensive care patients) · Adult patients in intensive care Pulmonary artery catheters for adult patients in intensive care (2013) · Cochrane | no estimate extracted | 4 studies · 2723 participants | High |
Intervention NR Hospital length of stay (general intensive care patients) · Adult patients in intensive care Pulmonary artery catheters for adult patients in intensive care (2013) · Cochrane | no estimate extracted | 2 studies · 1689 participants | High |
Intervention NR Hospital length of stay (high‐risk surgical patients) · Adult patients in intensive care Pulmonary artery catheters for adult patients in intensive care (2013) · Cochrane | no estimate extracted | 5 studies · 503 participants | High |
Intervention NR Cost of care (hospital charges, 1000s of US dollars) · Adult patients in intensive care Pulmonary artery catheters for adult patients in intensive care (2013) · Cochrane | no estimate extracted | 2 studies · 191 participants | Low |
Intervention NR Combined mortality of all studies · Adult patients in intensive care Pulmonary artery catheters for adult patients in intensive care (2013) · Cochrane | RR 1.01 | 13 studies · 5686 participants | High |
Primary analysis: less vs more frequent Catheter‐related BSI as defined using criteria specified by Maki 2006; Mermel 2009; and O'Grady 2002 · patients with intravenous administration set replacement Optimal timing for intravascular administration set replacement (2013) · Cochrane | RR 1.06 [0.66, 1.68] | 8 studies · 1794 participants | Low |
Primary analysis: less vs more frequent Infusate‐related BSI as defined using criteria specified by O'Grady 2002 · patients with intravenous administration set replacement Optimal timing for intravascular administration set replacement (2013) · Cochrane | RR 0.69 [0.31, 1.51] | 11 studies · 1847 participants | Low |
Primary analysis: less vs more frequent Infusate colonization any positive quantitative culture of infusate · patients with intravenous administration set replacement Optimal timing for intravascular administration set replacement (2013) · Cochrane | RR 1.15 [0.7, 1.86] | 8 studies · 1549 participants | Low |
Primary analysis: less vs more frequent Catheter colonization any positive semiquantitative or quantitative culture from the distal catheter segment · patients with intravenous administration set replacement Optimal timing for intravascular administration set replacement (2013) · Cochrane | RR 1.08 [0.94, 1.24] | 4 studies · 1448 participants | Moderate |
Primary analysis: less vs more frequent All‐cause BSI any positive blood culture drawn from a peripheral vein taken whilst the IVD is in situ, or within 48 hours of removal (O'Grady 2002) · patients with intravenous administration set replacement Optimal timing for intravascular administration set replacement (2013) · Cochrane | RR 0.82 [0.48, 1.4] | 6 studies · 2297 participants | Low |
Primary analysis: less vs more frequent Mortality · patients with intravenous administration set replacement Optimal timing for intravascular administration set replacement (2013) · Cochrane | RR 1.85 [1.01, 3.38] | 2 studies · 1355 participants | Low |
Intervention NR d mortality · mechanically ventilated participants with acute lung injury and acute respiratory distress syndrome Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute… (2013) · Cochrane | no estimate extracted | 2 studies · 302 participants | Low |
Intervention NR Number of days free of mechanical ventilation in a 28 d period · mechanically ventilated participants with acute lung injury and acute respiratory distress syndrome Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute… (2013) · Cochrane | no estimate extracted | 2 studies · 302 participants | Low |
Intervention NR Adverse events · mechanically ventilated participants with acute lung injury and acute respiratory distress syndrome Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute… (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Hypoxia · mechanically ventilated participants with acute lung injury and acute respiratory distress syndrome Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute… (2013) · Cochrane | no estimate extracted | 2 studies · 302 participants | Low |
Intervention NR Pneumothorax · mechanically ventilated participants with acute lung injury and acute respiratory distress syndrome Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute… (2013) · Cochrane | no estimate extracted | 2 studies · 302 participants | Low |
Intervention NR Hypotension · mechanically ventilated participants with acute lung injury and acute respiratory distress syndrome Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute… (2013) · Cochrane | no estimate extracted | 2 studies · 302 participants | Low |
Intervention NR Bradycardia · mechanically ventilated participants with acute lung injury and acute respiratory distress syndrome Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute… (2013) · Cochrane | no estimate extracted | 2 studies · 302 participants | Low |
Intervention NR Cardiac arrest · mechanically ventilated participants with acute lung injury and acute respiratory distress syndrome Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute… (2013) · Cochrane | no estimate extracted | 2 studies · 302 participants | Low |
Noninvasive vs invasive weaning Mortality—COPD · intubated adults with respiratory failure Noninvasive positive‐pressure ventilation as a weaning strategy for intubated adults with respiratory failure (2013) · Cochrane | RR 0.36 [0.24, 0.56] | 9 studies · 632 participants | Moderate |
Noninvasive vs invasive weaning Mortality—mixed · intubated adults with respiratory failure Noninvasive positive‐pressure ventilation as a weaning strategy for intubated adults with respiratory failure (2013) · Cochrane | RR 0.81 [0.47, 1.4] | 7 studies · 362 participants | Low |
Noninvasive vs invasive weaning Weaning failure · patients with intubated adults with respiratory failure Noninvasive positive‐pressure ventilation as a weaning strategy for intubated adults with respiratory failure (2013) · Cochrane | RR 0.63 [0.42, 0.96] | 8 studies · 605 participants | Moderate |
Noninvasive vs invasive weaning Nosocomial pneumonia · patients with intubated adults with respiratory failure Noninvasive positive‐pressure ventilation as a weaning strategy for intubated adults with respiratory failure (2013) · Cochrane | RR 0.25 [0.15, 0.43] | 14 studies · 953 participants | Low |
Noninvasive vs invasive weaning Average duration of ventilation related to weaning · patients with intubated adults with respiratory failure Noninvasive positive‐pressure ventilation as a weaning strategy for intubated adults with respiratory failure (2013) · Cochrane | no estimate extracted | 9 studies · 645 participants | Low |
Noninvasive vs invasive weaning Reintubation · patients with intubated adults with respiratory failure Noninvasive positive‐pressure ventilation as a weaning strategy for intubated adults with respiratory failure (2013) · Cochrane | RR 0.65 [0.44, 0.97] | 10 studies · 789 participants | Moderate |
Intervention NR Reduction in airway resistance Measured as a reduction in additional effective resistance (ΔRrs) and interrupter resistance (Rint) Assessed before treatment and 30 minutes after the end of each modality of administration · mechanically ventilated adults with need for aerosol bronchodilator therapy Metered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving… (2013) · Cochrane | no estimate extracted | 2 studies · 28 participants | Moderate |
Intervention NR Mortality during critical care unit admission Measured using mortality rate in intervention and comparison groups During critical care admission · mechanically ventilated adults with need for aerosol bronchodilator therapy Metered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving… (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Duration of mechanical ventilation Measured as number of days · mechanically ventilated adults with need for aerosol bronchodilator therapy Metered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving… (2013) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse changes to haemodynamic observations Measured as a change in heart rate (beats per minute) Assessed before treatment and 30 minutes after the end of each modality of administration · mechanically ventilated adults with need for aerosol bronchodilator therapy Metered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving… (2013) · Cochrane | no estimate extracted | 2 studies · 28 participants | Moderate |
Fibrinogen concentrate vs any comparator Mortality · bleeding patients or at risk of severe bleeding Fibrinogen concentrate in bleeding patients (2013) · Cochrane | RR 0.28 [0.03, 2.33] | 2 studies · 81 participants | Very low |
Fibrinogen concentrate vs any comparator Incidence of allogenic blood transfusion Proportion of participants transfused with RBC, FFP, PLT and/or cryo · bleeding patients or at risk of severe bleeding Fibrinogen concentrate in bleeding patients (2013) · Cochrane | RR 0.47 [0.31, 0.72] | 5 studies · 207 participants | Very low |
Fibrinogen concentrate vs any comparator Thrombotic episodes (arterial and venous graft occlusion, pulmonary embolus, deep venous thrombosis) Proportion with event · bleeding patients or at risk of severe bleeding Fibrinogen concentrate in bleeding patients (2013) · Cochrane | RR 1.03 [0.27, 3.97] | 3 studies · 124 participants | Very low |
Fibrinogen concentrate vs any comparator Intensive care unit (ICU) stay Duration of stay (hours) · bleeding patients or at risk of severe bleeding Fibrinogen concentrate in bleeding patients (2013) · Cochrane | no estimate extracted | 3 studies · 112 participants | Very low |
Fibrinogen concentrate vs any comparator Re‐operation due to persistent bleeding Events during admission · bleeding patients or at risk of severe bleeding Fibrinogen concentrate in bleeding patients (2013) · Cochrane | RR 0.68 [0.01, 36.71] | 2 studies · 124 participants | Very low |
Internal jugular vs subclavian insertion: long‐term catheterization Catheter‐related infectious complications ‐ Exit site infection · cancer patients Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane | RR 7 [0.88, 55.86] | 1 study · 200 participants | Low |
Femoral vs subclavian insertion: short‐term catheterization Immediate mechanical complications ‐ Total mechanical complications · critically ill patients Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane | RR 0.92 [0.56, 1.51] | 1 study · 289 participants | High |
Femoral vs subclavian insertion: short‐term catheterization Immediate mechanical complications ‐ Major mechanical complications · critically ill patients Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane | RR 0.5 [0.09, 2.67] | 1 study · 289 participants | High |
Femoral vs internal jugular insertion: short‐term catheterization Catheter‐related infectious complications ‐ Catheter colonization · critically ill patients who were expected to require support with renal replacement therapy Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane | RR 1.04 [0.8, 1.36] | 1 study · 637 participants | Moderate |
Femoral vs internal jugular insertion: short‐term catheterization Catheter‐related infectious complications ‐ Catheter related bloodstream infection · critically ill patients who were expected to require support with renal replacement therapy Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane | RR 0.58 [0.14, 2.4] | 1 study · 637 participants | Moderate |
Femoral vs internal jugular insertion: short‐term catheterization Catheter‐related infectious complication ‐ Subgroup Analysis for the effect of BMI on catheter colonization ‐ Highest BMI tercile (>28.4) · critically ill patients who were expected to require support with renal replacement therapy Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane | RR 1.69 [1.08, 2.65] | 1 study · 202 participants | Moderate |
Femoral vs internal jugular insertion: short‐term catheterization Catheter‐related thrombotic complications ‐ Symptomatic deep venous thrombosis · critically ill patients who were expected to require support with renal replacement therapy Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane | RR 0.99 [0.14, 6.98] | 1 study · 736 participants | Moderate |
Femoral vs internal jugular insertion: short‐term catheterization Catheter‐related thrombotic complications ‐ Catheter related thrombosis · critically ill patients who were expected to require support with renal replacement therapy Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane | RR 0.46 [0.21, 1.01] | 1 study · 151 participants | Moderate |
Femoral vs internal jugular insertion: short‐term catheterization Immediate mechanical complications ‐ Total mechanical complications · critically ill patients who were expected to require support with renal replacement therapy Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane | RR 0.51 [0.29, 0.88] | 1 study · 736 participants | Moderate |
Femoral vs internal jugular insertion: short‐term catheterization Immediate mechanical complications ‐ Major mechanical complications · critically ill patients who were expected to require support with renal replacement therapy Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane | RR 0.33 [0.03, 3.16] | 1 study · 736 participants | Moderate |
Internal jugular vs subclavian insertion: long‐term catheterization Catheter‐related infectious complications ‐ Port‐related bacteraemia and/or pocket infections · cancer patients Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane | RR 0.35 [0.04, 3.32] | 1 study · 240 participants | Moderate |
Internal jugular vs subclavian insertion: long‐term catheterization Catheter‐related thrombotic complications · cancer patients Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane | RR 1.97 [0.87, 4.48] | 1 study · 240 participants | Moderate |
Internal jugular vs subclavian insertion: long‐term catheterization Immediate mechanical complications ‐ Total mechanical complications · cancer patients Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane | RR 1 [0.21, 4.84] | 2 studies · 468 participants | Low |
Internal jugular vs subclavian insertion: long‐term catheterization Immediate mechanical complications ‐ Major mechanical complications · cancer patients Central venous access sites for the prevention of venous thrombosis, stenosis and infection (2012) · Cochrane | RR 0.33 [0.01, 8.09] | 2 studies · 468 participants | Low |